#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Wuerzburg

  • Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Chronic lymphocytic leukaemia
    Investigated drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Austria Germany Portugal
  • Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Dexamethasone Ph. Eur.
    • Talquetamab
    • Teclistamab
    Austria Belgium Czechia Denmark France Germany +8
  • Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Petosemtamab
    • Cetuximab
    • Docetaxel
    Belgium Czechia France Germany Greece Hungary +6
  • Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Petosemtamab
    • Pembrolizumab
    Austria Belgium Croatia Czechia France Germany +8
  • Study on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions

    Recruiting

    2 1 1 1
    Investigated drugs:
    • AUTOLOGOUS T-CELLS TRANSDUCED WITH THE LENTIVIRAL LV-R11KEA ENCODING T-CELL RECEPTOR TARGETING PATIENT-SPECIFIC TUMOR-ASSOCIATED ANTIGENS
    • Ima203Cd8
    • Nivolumab
    Germany
  • Study on the Safety and Effectiveness of Teclistamab and Talquetamab for Patients with Newly Diagnosed Multiple Myeloma Eligible for Transplant

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Talquetamab
    • Teclistamab
    • Betamethasone Sodium Phosphate
    Germany
Previous Page
1 … 14 15 16 17 18 … 69
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Dexamethasone Carboplatin Cyclophosphamide Cisplatin Pembrolizumab Lenalidomide Etoposide Vincristine Sulfate Bortezomib Doxorubicin Hydrochloride Tocilizumab Daratumumab Rituximab Prednisolone Fluorouracil Prednisone Mycophenolate Mofetil Oxaliplatin Pomalidomide Nivolumab Paracetamol Infliximab Durvalumab Atezolizumab Carfilzomib Docetaxel Ifosfamide Cytarabine Venetoclax Sodium Chloride Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acoustic neuroma Acromegaly Acute graft versus host disease Acute graft versus host disease in intestine Acute kidney injury Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Adenocarcinoma gastric Adenocarcinoma of colon Adenocarcinoma pancreas Adrenocortical carcinoma Adrenogenital syndrome Age-related macular degeneration Alcoholic liver disease Allogenic stem cell transplantation Amyotrophic lateral sclerosis Anaplastic large cell lymphoma T- and null-cell types Apheresis Arteriosclerosis Atypical teratoid/rhabdoid tumour of CNS Autism spectrum disorder Autoimmune disorder Axial spondyloarthritis B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory B-cell type acute leukaemia Back pain Biliary cancer metastatic Bladder cancer Bladder transitional cell carcinoma Breast cancer Breast cancer female Breast cancer male Breast cancer metastatic Breast cancer recurrent Breast cancer stage I Breast cancer stage II Breast cancer stage III Bronchopulmonary aspergillosis Bronchopulmonary dysplasia Cachexia Carcinoid syndrome Cardiac amyloidosis Cardiac failure Cardiac function disturbance postoperative Cardiomyopathy Cardiovascular disorder Central nervous system lymphoma Cholangiocarcinoma Cholangitis sclerosing Chronic cutaneous lupus erythematosus Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic lymphocytic leukaemia refractory Chronic myeloid leukaemia Chronic rhinosinusitis with nasal polyps Colon cancer stage II Colon cancer stage III Colon cancer stage IV Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Colorectal cancer stage III Colorectal cancer stage IV Coronary artery disease Critical illness Crohn's disease Cushing's syndrome Cutaneous lupus erythematosus Cystic fibrosis Cytokine release syndrome Deafness neurosensory Diabetic neuropathy Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma recurrent Diffuse large B-cell lymphoma refractory Dilated cardiomyopathy DNA mismatch repair protein gene mutation Dry age-related macular degeneration Dry eye Ductal adenocarcinoma of pancreas Encephalitis autoimmune Ependymoma Epstein-Barr virus associated lymphoma Ewing's sarcoma Fabry's disease Follicle centre lymphoma follicular grade I II - III refractory Follicular lymphoma Gallbladder cancer Gastroenteropancreatic neuroendocrine tumour disease Gastrooesophageal cancer Germ cell cancer Glioma Glomerulonephritis membranoproliferative Glomerulonephritis membranous Gout Graft versus host disease Haematological malignancy Head and neck cancer Head and neck cancer metastatic Head and neck cancer stage III Head and neck cancer stage IV Hepatic cancer Hepatic cirrhosis Hepatic fibrosis Hepatoblastoma Hepatocellular carcinoma HER2 positive biliary tract cancer HER2 positive breast cancer Hereditary hypophosphataemic rickets Herpes simplex Hidradenitis High-grade B-cell lymphoma Hodgkin's disease Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Human epidermal growth factor receptor negative Hypertrophic cardiomyopathy Hyponatraemia Hypoparathyroidism Hypophosphatasia Idiopathic pulmonary fibrosis IgA nephropathy Infection in an immunocompromised host Inflammation Intensive care Interstitial lung disease Ischaemic stroke K-ras gene mutation Laryngeal cancer Lung neoplasm malignant Malignant glioma Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage III Malignant melanoma stage IV Mantle cell lymphoma Mantle cell lymphoma refractory Mantle cell lymphoma stage II Mantle cell lymphoma stage III Mantle cell lymphoma stage IV Marginal zone lymphoma Marginal zone lymphoma refractory Medullary thyroid cancer Medulloblastoma Melanoma recurrent Metabolic acidosis Metabolic dysfunction-associated steatohepatitis Metastatic malignant melanoma Multifocal motor neuropathy Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Nasopharyngeal cancer Neonatal respiratory distress syndrome Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephroblastoma Neuroblastoma Neurodermatitis Neuroendocrine carcinoma Neuroendocrine carcinoma of the skin Neuroendocrine tumour Neurofibroma Neurofibromatosis Neuropathy peripheral Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage I Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Oesophageal adenocarcinoma Osteoarthritis Osteogenesis imperfecta Osteosarcoma Ovarian cancer metastatic Pain Pancreatic carcinoma Pancreatic carcinoma metastatic Pancreatic carcinoma stage IV Pancreatic neoplasm Pancreatic neuroendocrine tumour Paresis Parkinson's disease Pemphigoid Plasma cell myeloma Plasma cell myeloma refractory Pneumonia respiratory syncytial viral Post-acute COVID-19 syndrome Primary amyloidosis Primary hyperaldosteronism Progressive relapsing multiple sclerosis Progressive supranuclear palsy Prophylaxis against transplant rejection Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer metastatic Prostate cancer recurrent Psoriasis Pulmonary arterial hypertension Pulmonary fibrosis Pyoderma gangrenosum Pyruvate kinase deficiency anaemia Rectal cancer Rectal cancer stage II Rectal cancer stage III Relapsing multiple sclerosis Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Respiratory tract infection Retinal artery occlusion Rhabdomyosarcoma Secondary progressive multiple sclerosis Sepsis Septic shock Sjogren's syndrome Skin ulcer Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer metastatic Small cell lung cancer recurrent Small intestine neuroendocrine tumour Squamous cell carcinoma of head and neck Squamous cell carcinoma of the hypopharynx Staphylococcal bacteraemia Subacute cutaneous lupus erythematosus Systemic candida Systemic scleroderma Thermal burn Transitional cell carcinoma Triple negative breast cancer Trisomy 21 Uveal melanoma Vitamin D deficiency Waldenstrom's macroglobulinaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!